View our recent Webcast Recording on TissueInsight®: Realizing the Clinical Diagnostic Potential of Digital Pathology.

YOUR ADVANTAGE IN TISSUE-BASED PRECISION MEDICINE

Dramatically shorten your drug development timeline + improve chances of success through more informative tissue analysis

MULTIPLEX IMMUNO-FLUORESCENCE ASSAYS

Learn more about what is happening in the tumor microenvironment of your tissue sample

CDx DEVELOPMENT

Benefit from our vast experience developing novel pathology tests in a regulated setting

REGULATORY STRATEGY AND SUPPORT

Our successful track record working directly with the FDA can help ensure your therapeutic success

Flagship Biosciences Is Honored with a Best Practices Award

Join us at the AACR Annual Conference

Learn More >

Appointment of Gina Wallar, Ph.D., MPH as new CCO

Our sophisticated spatial biology and biomarker analysis solutions give you a distinct advantage in drug development and clinical diagnostics

Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated pathology world.

From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.

Our unique, proprietary image analysis technology provides thousands of measurements on every cell across an entire slide for validated spatial insights on every sample. Flagship’s technology, team, and proven process have provided superior data for hundreds of clinical trials.

The Flagship approach:

Saves time and money in predicting patient response and demonstrating mechanisms of action
Dramatically improves accuracy
Accelerates the development process through more robust data
Enriches the clinical diagnostics decision-making process

Quite simply, we’re changing the drug development paradigm.

Our Services

Pharma

Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.

Clinical Diagnostics

Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.

Download our recent white paper,
“Tissue Image Analysis and Biomarker Assessment Implementation Benefits and ROI”

Benefits of Collaborating with Flagship

More accurate and informative tissue data and analytics

Collaboration with our world-renowned scientific team

Increased speed to market for your drug development programs

Enriched clinical diagnostics process for better outcomes